Article Versions Notes

Stoddard SV, Wallace FE, Stoddard SD, Cheng Q, Acosta D, Barzani S, Bobay M, Briant J, Cisneros C, Feinstein S, et al. In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains. Biophysica. 2021; 1(3):311-327. https://doi.org/10.3390/biophysica1030023

Stoddard, Shana V., Felissa E. Wallace, Serena D. Stoddard, Qianyi Cheng, Daniel Acosta, Shaliz Barzani, Marissa Bobay, Jared Briant, Christian Cisneros, Samantha Feinstein, and et al. 2021. "In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains" Biophysica 1, no. 3: 311-327. https://doi.org/10.3390/biophysica1030023

Stoddard, S. V., Wallace, F. E., Stoddard, S. D., Cheng, Q., Acosta, D., Barzani, S., Bobay, M., Briant, J., Cisneros, C., Feinstein, S., Glasper, K., Hussain, M., Lidoski, A., Lingareddy, P., Lovett, G., Matherne, L., McIntosh, J., Moosani, N., Nagge, L., ... Vaghela, S. (2021). In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains. Biophysica, 1(3), 311-327. https://doi.org/10.3390/biophysica1030023